Crucially, not all tumor antigens can be considered oncoantigens due to their cellular location (e.g., MAGE) or because they are not drivers of tumor growth (e.g., carcinoembryonic antigen (CEA)) [106]. The gene discussed is CEACAM5; the disease is neoplasm.